Bioactive Lipid Mediators in Cardiopulmonary Pharmacology

Preface Darryl C. Zeldin and John Seubert 1. Bioactive lipids in hypertension John D. Imig 2. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response Mohammed A. Nayeem, Werner J. Geldenhuys and Ahmad Hanif 3. Cyclooxygenases, eicosanoids and platelets Annalisa Bruno, Stefania Tacconelli, Annalisa Contursi, Patrizia Ballerini and Paola Patrignani 4. The roles of eicosanoids in myocardial diseases Zuowen He and Dao Wen Wang 5. Cardioprotective mechanisms of cytochrome P450 derived oxylipins from ¿-3 and ¿-6 PUFAs Christi Cho, Theresa Aliwarga, Alexandra M. Wiley and Rheem A. Totah 6. 20-Hydroxyeicosatetraenoic acid (20-HETE): Bioactions, receptors, vascular function, cardiometabolic disease and beyond Jonathan V. Pascale, Alexandra Wolf, Yonaton Kadish, Danielle Diegisser, Melissa-Maria Kulaprathazhe, Danait Yemane, Samir Ali, Namhee Kim, David E. Baruch, Muhamad Afiq Faisal Bin Yahaya, Ercument Dirice, Adeniyi M. Adebesin, John R. Falck, Michal L. Schwartzman and Victor Garcia 7. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease Matthew Spite and Gabrielle Fredman 8. Cytochrome P450-derived eicosanoids in brain: From basic discovery to clinical translation Catherine M. Davis, Aseel H. Ibrahim and Nabil J. Alkayed 9. Lipid mediators generated by the cytochrome P450: Epoxide hydrolase pathway Timo Frömel, Jiong Hu and Ingrid Fleming 10. Role of omega-3 and omega-6 endocannabinoids in cardiopulmonary pharmacology Tiffany Y.-C. Tang, Justin S. Kim and Aditi Das 11. Oxylipins in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) Kimberley Cousins, Chien-Chang Chen, Esha Sehanobish and Elina Jerschow